These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 28689065)

  • 1. Improve the anticancer potency of the platinum(II) complexes through functionalized leaving group.
    Zhao J; Wang D; Xu G; Gou S
    J Inorg Biochem; 2017 Oct; 175():20-28. PubMed ID: 28689065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and characterization of platinum(II) and (IV) complexes of 1,3-diaminepropane and 1,4-diaminebutane: circumvention of cisplatin resistance and DNA interstrand cross-link formation in CH1cisR ovarian tumor cells.
    Alvarez-Valdés A; Pérez JM; López-Solera I; Lannegrand R; Continente JM; Amo-Ochoa P; Camazón MJ; Solans X; Font-Bardía M; Navarro-Ranninger C
    J Med Chem; 2002 Apr; 45(9):1835-44. PubMed ID: 11960495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of platinum(II)-assisted platinum(IV) substitution for the oxidation of guanosine derivatives by platinum(IV) complexes.
    Choi S; Vastag L; Larrabee YC; Personick ML; Schaberg KB; Fowler BJ; Sandwick RK; Rawji G
    Inorg Chem; 2008 Feb; 47(4):1352-60. PubMed ID: 18220340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulatory effect of axial and equatorial ligands on antitumor activities of trans-1R,2R-diaminocyclohexane platinum(IV) complexes.
    Siddik ZH; al-Baker S; Thai G; Khokhar AR
    Anticancer Drug Des; 1994 Apr; 9(2):139-51. PubMed ID: 8166929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and anticancer activity of [2-hydroxy-1,3-diaminopropane-kappa 2N,N'] platinum(II) complexes.
    Liu W; Chen X; Xie M; Lou L; Ye Q; Yu Y; Hou S
    J Inorg Biochem; 2008 Oct; 102(10):1942-6. PubMed ID: 18707762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor platinum(II) complexes of N-monoalkyl 1R,2R-diamino-cyclohexanes with 3-(nitrooxy)cyclobutane-1,1-dicarboxylate as a leaving group.
    Zhao J; Gou S; Xu G; Cheng L
    Eur J Med Chem; 2014 Oct; 85():408-17. PubMed ID: 25108080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dinuclear Platinum(II) Complexes with Bone-Targeting Groups as Potential Anti-Osteosarcoma Agents.
    Zhang Z; Wang X; Luo C; Zhu C; Wang K; Zhang C; Guo Z
    Chem Asian J; 2017 Jul; 12(13):1659-1667. PubMed ID: 28556606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. East-west fusion-necrosis and apoptosis acting in concert by demethylcantharidin-integrated platinum complexes.
    Pang SK; So WK; Ho YP; Au-Yeung CF
    Anticancer Agents Med Chem; 2014 Jun; 14(5):756-61. PubMed ID: 24476313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of different chelating leaving groups on the substitution kinetics of mononuclear Pt(II)(1,2-trans-R,R-diaminocyclohexane)(X-Y) complexes.
    Summa N; Soldatović T; Dahlenburg L; Bugarcić ZD; van Eldik R
    J Biol Inorg Chem; 2007 May; 12(4):461-75. PubMed ID: 17245597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New imidoyl-indazole platinum (II) complexes as potential anticancer agents: Synthesis, evaluation of cytotoxicity, cell death and experimental-theoretical DNA interaction studies.
    Cabrera AR; Espinosa-Bustos C; Faúndez M; Meléndez J; Jaque P; Daniliuc CG; Aguirre A; Rojas RS; Salas CO
    J Inorg Biochem; 2017 Sep; 174():90-101. PubMed ID: 28648925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and cytotoxicity of platinum(II) complexes of a physiologically active carrier histamine.
    Chen XZ; Ye QS; Lou LG; Xie MJ; Liu WP; Yu Y; Hou SQ
    Arch Pharm (Weinheim); 2008 Feb; 341(2):132-6. PubMed ID: 18186542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, characterization, and biological evaluation of new tetrazole-based platinum(II) and palladium(II) chlorido complexes--potent cisplatin analogues and their trans isomers.
    Serebryanskaya TV; Yung T; Bogdanov AA; Shchebet A; Johnsen SA; Lyakhov AS; Ivashkevich LS; Ibrahimava ZA; Garbuzenco TS; Kolesnikova TS; Melnova NI; Gaponik PN; Ivashkevich OA
    J Inorg Biochem; 2013 Mar; 120():44-53. PubMed ID: 23305964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent anticancer activity and possible low toxicity of platinum(II) complexes with functionalized 1,1-cyclobutanedicarboxylate as a leaving ligand.
    Zhao J; Gou S; Liu F
    Chemistry; 2014 Nov; 20(46):15216-25. PubMed ID: 25256173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relevance of the leaving group for antitumor activity of new platinum(II) compounds containing anthracene derivatives as a carrier ligand.
    Marqués-Gallego P; Contaldi S; den Dulk H; Monari M; Brouwer J; Jaehde U; Kalayda GV; Reedijk J
    J Inorg Biochem; 2009 Dec; 103(12):1602-8. PubMed ID: 19783310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and analysis of the anticancer activity of platinum(II) complexes incorporating dipyridoquinoxaline variants.
    Pages BJ; Li F; Wormell P; Ang DL; Clegg JK; Kepert CJ; Spare LK; Danchaiwijit S; Aldrich-Wright JR
    Dalton Trans; 2014 Nov; 43(41):15566-75. PubMed ID: 25197979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, cytotoxicity, and apoptosis induction study of antitumor dinuclear platinum(II) complexes.
    Xu G; Gou S; Gao C
    Arch Pharm (Weinheim); 2013 Apr; 346(4):308-13. PubMed ID: 23447402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-Acting Mitochondria-Targeted Platinum(IV) Prodrugs of Kiteplatin with α-Lipoic Acid in the Axial Positions.
    Savino S; Marzano C; Gandin V; Hoeschele JD; Natile G; Margiotta N
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30011897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxicity and cellular response mechanisms of water-soluble platinum(II) complexes of lidocaine and phenylcyanamide derivatives.
    Tabrizi L; Chiniforoshan H
    Biometals; 2017 Feb; 30(1):59-70. PubMed ID: 27995355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New Pt-NNSO core anticancer agents: Structural optimization and investigation of their anticancer activity.
    Chong SX; Jin Y; Au-Yeung SC; To KK
    J Inorg Biochem; 2017 May; 170():34-45. PubMed ID: 28214754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thermodynamic and kinetic studies on reactions of Pt(II) complexes with biologically relevant nucleophiles.
    Summa N; Schiessl W; Puchta R; van Eikema Hommes N; van Eldik R
    Inorg Chem; 2006 Apr; 45(7):2948-59. PubMed ID: 16562950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.